$ABIO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARCA biopharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ARCA biopharma, Inc.. Get notifications about new insider transactions in ARCA biopharma, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Buy | P | 3.19 | 10,000 | 31,947 | 50,000 | 40 K to 50 K (+25.00 %) |
| Jan 13 2021 | ABIO | ARCA biopharma, In ... | Hove Anders D | Director | Option Exercise | A | 4.31 | 12,000 | 51,720 | 12,000 | |
| Jan 13 2021 | ABIO | ARCA biopharma, In ... | Woosley Raymond L. | Director | Option Exercise | A | 4.31 | 12,000 | 51,720 | 12,000 | |
| Jan 13 2021 | ABIO | ARCA biopharma, In ... | Grais Linda | Director | Option Exercise | A | 4.31 | 12,000 | 51,720 | 12,000 | |
| Jan 13 2021 | ABIO | ARCA biopharma, In ... | MITCHELL DANIEL J | Director | Option Exercise | A | 4.31 | 12,000 | 51,720 | 12,000 | |
| Jan 13 2021 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Option Exercise | A | 4.31 | 12,000 | 51,720 | 12,000 | |
| Dec 23 2020 | ABIO | ARCA biopharma, In ... | Keuer Thomas A | Chief Operating Off ... | Option Exercise | A | 4.27 | 70,000 | 298,900 | 70,000 | |
| Dec 23 2020 | ABIO | ARCA biopharma, In ... | Keuer Thomas A | Chief Operating Off ... | Option Exercise | A | 4.27 | 70,000 | 298,900 | 70,000 | |
| Dec 21 2020 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Buy | P | 4.16 | 10,000 | 41,630 | 30,000 | 20 K to 30 K (+50.00 %) |
| Sep 25 2020 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Buy | P | 4.28 | 5,000 | 21,400 | 20,000 | 15 K to 20 K (+33.33 %) |
| Sep 24 2020 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Buy | P | 4.66 | 3,056 | 14,241 | 15,000 | 11.9 K to 15 K (+25.59 %) |
| Sep 21 2020 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Buy | P | 4.77 | 10,000 | 47,660 | 11,944 | 1.9 K to 11.9 K (+514.40 %) |
| Apr 03 2018 | ABIO | ARCA biopharma, In ... | Keuer Thomas A | Chief Operating Off ... | Sell | S | 0.50 | 482 | 242 | 13,153 | 13.6 K to 13.2 K (-3.54 %) |
| Mar 05 2018 | ABIO | ARCA biopharma, In ... | MITCHELL DANIEL J | Director | Option Exercise | A | 0.72 | 8,000 | 5,760 | 8,000 | |
| Mar 05 2018 | ABIO | ARCA biopharma, In ... | Hove Anders D | Director | Option Exercise | A | 0.72 | 8,000 | 5,760 | 8,000 | |
| Feb 28 2018 | ABIO | ARCA biopharma, In ... | VENROCK HEALTHCARE CAPITAL PAR ... | 10% Owner | Sell | S | 0.53 | 41,331 | 21,905 | 0 | 41.3 K to 0 (-100.00 %) |
| Feb 28 2018 | ABIO | ARCA biopharma, In ... | VENROCK HEALTHCARE CAPITAL PAR ... | 10% Owner | Sell | S | 0.55 | 1,500,000 | 825,000 | 41,331 | 1.5 M to 41.3 K (-97.32 %) |
| Feb 27 2018 | ABIO | ARCA biopharma, In ... | Sonsini Peter W. | 10% Owner | Sell | S | 0.50 | 1,460,209 | 731,273 | 0 | 1.5 M to 0 (-100.00 %) |
| Feb 27 2018 | ABIO | ARCA biopharma, In ... | SANDELL SCOTT D | 10% Owner | Sell | S | 0.50 | 1,460,209 | 731,273 | 0 | 1.5 M to 0 (-100.00 %) |
| Feb 27 2018 | ABIO | ARCA biopharma, In ... | Sakoda Jon | 10% Owner | Sell | S | 0.50 | 1,460,209 | 731,273 | 0 | 1.5 M to 0 (-100.00 %) |
| Feb 27 2018 | ABIO | ARCA biopharma, In ... | MOTT DAVID M | 10% Owner | Sell | S | 0.50 | 1,460,209 | 731,273 | 0 | 1.5 M to 0 (-100.00 %) |
| Feb 27 2018 | ABIO | ARCA biopharma, In ... | MAKOWER JOSHUA | 10% Owner | Sell | S | 0.50 | 1,460,209 | 731,273 | 0 | 1.5 M to 0 (-100.00 %) |
| Feb 27 2018 | ABIO | ARCA biopharma, In ... | Florence Anthony A. Jr. | 10% Owner | Sell | S | 0.50 | 1,460,209 | 731,273 | 0 | 1.5 M to 0 (-100.00 %) |
| Feb 27 2018 | ABIO | ARCA biopharma, In ... | BASKETT FOREST | 10% Owner | Sell | S | 0.50 | 1,460,209 | 731,273 | 0 | 1.5 M to 0 (-100.00 %) |
| Feb 27 2018 | ABIO | ARCA biopharma, In ... | BARRIS PETER J | 10% Owner | Sell | S | 0.50 | 1,460,209 | 731,273 | 0 | 1.5 M to 0 (-100.00 %) |
| Feb 27 2018 | ABIO | ARCA biopharma, In ... | Growth Equity Opportunities IV ... | 10% Owner | Sell | S | 0.50 | 1,460,209 | 731,273 | 0 | 1.5 M to 0 (-100.00 %) |
| Jul 17 2017 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Buy | P | 2.49 | 10,000 | 24,900 | 35,000 | 25 K to 35 K (+40.00 %) |
| May 03 2017 | ABIO | ARCA biopharma, In ... | MITCHELL DANIEL J | Director | Buy | P | 2.71 | 11,000 | 29,810 | 11,000 | 0 to 11 K |
| Apr 05 2017 | ABIO | ARCA biopharma, In ... | Selby Brian L. | VP, Finance | Sell | S | 2.46 | 1,114 | 2,740 | 1,275 | 2.4 K to 1.3 K (-46.63 %) |
| Apr 05 2017 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | S.V.P., General Cou ... | Sell | S | 2.41 | 418 | 1,007 | 17,517 | 17.9 K to 17.5 K (-2.33 %) |
| Apr 05 2017 | ABIO | ARCA biopharma, In ... | Keuer Thomas A | Chief Operating Off ... | Sell | S | 2.41 | 390 | 940 | 14,045 | 14.4 K to 14 K (-2.70 %) |
| Apr 05 2017 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | Pres. & Chief Execu ... | Sell | S | 2.41 | 720 | 1,735 | 41,155 | 41.9 K to 41.2 K (-1.72 %) |
| Mar 27 2017 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Buy | P | 2.59 | 25,000 | 64,750 | 25,000 | 0 to 25 K |
| Mar 01 2017 | ABIO | ARCA biopharma, In ... | Selby Brian L. | VP, Finance | Option Exercise | A | 2.60 | 24,100 | 62,660 | 24,100 | |
| Mar 01 2017 | ABIO | ARCA biopharma, In ... | Selby Brian L. | VP, Finance | Sell | S | 2.56 | 161 | 412 | 2,389 | 2.6 K to 2.4 K (-6.31 %) |
| Mar 01 2017 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | Pres. & Chief Execu ... | Option Exercise | A | 2.60 | 41,600 | 108,160 | 41,600 | |
| Mar 01 2017 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | Pres. & Chief Execu ... | Sell | S | 2.61 | 763 | 1,991 | 41,875 | 42.6 K to 41.9 K (-1.79 %) |
| Feb 21 2017 | ABIO | ARCA biopharma, In ... | Grais Linda S | Director | Option Exercise | A | 2.50 | 8,000 | 20,000 | 8,000 | |
| Feb 21 2017 | ABIO | ARCA biopharma, In ... | MITCHELL DANIEL J | Director | Option Exercise | A | 2.50 | 8,000 | 20,000 | 8,000 | |
| Feb 21 2017 | ABIO | ARCA biopharma, In ... | Selby Brian L. | VP, Finance | Option Exercise | A | 2.50 | 23,000 | 57,500 | 23,000 | |
| Feb 21 2017 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | S.V.P., General Cou ... | Option Exercise | A | 2.50 | 24,000 | 60,000 | 24,000 | |
| Feb 21 2017 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Option Exercise | A | 2.50 | 8,000 | 20,000 | 8,000 | |
| Feb 21 2017 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | Pres. & Chief Execu ... | Option Exercise | A | 2.50 | 42,000 | 105,000 | 42,000 | |
| Feb 21 2017 | ABIO | ARCA biopharma, In ... | Woosley Raymond L. | Director | Option Exercise | A | 2.50 | 8,000 | 20,000 | 8,000 | |
| Feb 21 2017 | ABIO | ARCA biopharma, In ... | Hove Anders D | Director | Option Exercise | A | 2.50 | 10,000 | 25,000 | 10,000 | |
| Feb 21 2017 | ABIO | ARCA biopharma, In ... | Keuer Thomas A | Chief Operating Off ... | Option Exercise | A | 2.50 | 25,200 | 63,000 | 25,200 | |
| Oct 18 2016 | ABIO | ARCA biopharma, In ... | Keuer Thomas A | Chief Operating Off ... | Sell | S | 2.45 | 483 | 1,184 | 14,900 | 15.4 K to 14.9 K (-3.14 %) |
| Sep 21 2016 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | Pres. & Chief Execu ... | Sell | S | 2.89 | 1,972 | 5,699 | 42,638 | 44.6 K to 42.6 K (-4.42 %) |
| Sep 21 2016 | ABIO | ARCA biopharma, In ... | Keuer Thomas A | Chief Operating Off ... | Sell | S | 2.89 | 714 | 2,063 | 15,383 | 16.1 K to 15.4 K (-4.44 %) |
| Sep 21 2016 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | S.V.P., General Cou ... | Sell | S | 2.89 | 1,185 | 3,425 | 18,400 | 19.6 K to 18.4 K (-6.05 %) |
| Sep 21 2016 | ABIO | ARCA biopharma, In ... | Selby Brian L. | VP, Finance | Sell | S | 2.91 | 476 | 1,385 | 2,550 | 3 K to 2.6 K (-15.73 %) |
| Jun 13 2016 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | Pres. & Chief Execu ... | Option Exercise | A | 3.30 | 55,400 | 182,820 | 55,400 | |
| Jun 13 2016 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | Pres. & Chief Execu ... | Option Exercise | A | 3.30 | 27,200 | 89,760 | 27,200 | |
| Jun 13 2016 | ABIO | ARCA biopharma, In ... | Keuer Thomas A | Chief Operating Off ... | Option Exercise | A | 3.30 | 31,700 | 104,610 | 31,700 | |
| Jun 13 2016 | ABIO | ARCA biopharma, In ... | Keuer Thomas A | Chief Operating Off ... | Option Exercise | A | 3.30 | 15,600 | 51,480 | 15,600 | |
| Jun 13 2016 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | S.V.P., General Cou ... | Option Exercise | A | 3.30 | 30,200 | 99,660 | 30,200 | |
| Jun 13 2016 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | S.V.P., General Cou ... | Option Exercise | A | 3.30 | 14,800 | 48,840 | 14,800 | |
| Jun 13 2016 | ABIO | ARCA biopharma, In ... | Selby Brian L. | VP, Finance | Option Exercise | A | 3.30 | 32,100 | 105,930 | 32,100 | |
| Jun 13 2016 | ABIO | ARCA biopharma, In ... | Selby Brian L. | VP, Finance | Option Exercise | A | 3.30 | 15,800 | 52,140 | 15,800 | |
| Apr 06 2016 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | See Remarks | Sell | S | 3.52 | 724 | 2,548 | 44,610 | 45.3 K to 44.6 K (-1.60 %) |
| Apr 06 2016 | ABIO | ARCA biopharma, In ... | Keuer Thomas A | Chief Operating Off ... | Sell | S | 3.52 | 384 | 1,352 | 16,097 | 16.5 K to 16.1 K (-2.33 %) |
| Apr 06 2016 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | S.V.P., General Cou ... | Sell | S | 3.52 | 366 | 1,288 | 19,585 | 20 K to 19.6 K (-1.83 %) |
| Apr 06 2016 | ABIO | ARCA biopharma, In ... | Selby Brian L. | VP, Finance | Sell | S | 3.52 | 1,114 | 3,921 | 3,026 | 4.1 K to 3 K (-26.91 %) |
| Mar 02 2016 | ABIO | ARCA biopharma, In ... | Keuer Thomas A | Chief Operating Off ... | Sell | S | 3.53 | 457 | 1,613 | 16,481 | 16.9 K to 16.5 K (-2.70 %) |
| Mar 02 2016 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | S.V.P., General Cou ... | Sell | S | 3.51 | 458 | 1,608 | 19,951 | 20.4 K to 20 K (-2.24 %) |
| Mar 02 2016 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | See Remarks | Sell | S | 3.50 | 752 | 2,632 | 45,334 | 46.1 K to 45.3 K (-1.63 %) |
| Mar 02 2016 | ABIO | ARCA biopharma, In ... | Selby Brian L. | VP, Finance | Sell | S | 3.46 | 160 | 554 | 4,140 | 4.3 K to 4.1 K (-3.72 %) |
| Feb 16 2016 | ABIO | ARCA biopharma, In ... | Grais Linda S | Director | Option Exercise | A | 3.44 | 8,000 | 27,520 | 8,000 | |
| Feb 16 2016 | ABIO | ARCA biopharma, In ... | Woosley Raymond L. | Director | Option Exercise | A | 3.44 | 8,000 | 27,520 | 8,000 | |
| Feb 16 2016 | ABIO | ARCA biopharma, In ... | MITCHELL DANIEL J | Director | Option Exercise | A | 3.44 | 8,000 | 27,520 | 8,000 | |
| Feb 16 2016 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Option Exercise | A | 3.44 | 8,000 | 27,520 | 8,000 | |
| Oct 19 2015 | ABIO | ARCA biopharma, In ... | Keuer Thomas A | Chief Operating Off ... | Sell | S | 5.14 | 496 | 2,549 | 16,938 | 17.4 K to 16.9 K (-2.85 %) |
| Sep 21 2015 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | See Remarks | Sell | S | 6.33 | 1,809 | 11,451 | 46,086 | 47.9 K to 46.1 K (-3.78 %) |
| Sep 21 2015 | ABIO | ARCA biopharma, In ... | Selby Brian L. | VP, Finance | Sell | S | 6.23 | 476 | 2,965 | 4,300 | 4.8 K to 4.3 K (-9.97 %) |
| Sep 21 2015 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | S.V.P., General Cou ... | Sell | S | 6.32 | 1,129 | 7,135 | 20,409 | 21.5 K to 20.4 K (-5.24 %) |
| Sep 21 2015 | ABIO | ARCA biopharma, In ... | Keuer Thomas A | Chief Operating Off ... | Sell | S | 6.33 | 680 | 4,304 | 17,407 | 18.1 K to 17.4 K (-3.76 %) |
| Mar 02 2015 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | See Remarks | Sell | S | 0.71 | 5,446 | 3,884 | 335,279 | 340.7 K to 335.3 K (-1.60 %) |
| Mar 02 2015 | ABIO | ARCA biopharma, In ... | Selby Brian L. | VP, Finance | Sell | S | 0.71 | 1,125 | 800 | 33,441 | 34.6 K to 33.4 K (-3.25 %) |
| Feb 17 2015 | ABIO | ARCA biopharma, In ... | Keuer Thomas A | Chief Operating Off ... | Option Exercise | A | 0.67 | 13,650 | 9,146 | 13,650 | |
| Feb 17 2015 | ABIO | ARCA biopharma, In ... | Keuer Thomas A | Chief Operating Off ... | Grant | A | 0.00 | 25,350 | 0 | 126,626 | 101.3 K to 126.6 K (+25.03 %) |
| Feb 17 2015 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Option Exercise | A | 0.67 | 8,000 | 5,360 | 8,000 | |
| Feb 17 2015 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | S.V.P., General Cou ... | Option Exercise | A | 0.67 | 12,950 | 8,677 | 12,950 | |
| Feb 17 2015 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | S.V.P., General Cou ... | Grant | A | 0.00 | 24,050 | 0 | 150,787 | 126.7 K to 150.8 K (+18.98 %) |
| Feb 17 2015 | ABIO | ARCA biopharma, In ... | Woosley Raymond L. | Director | Option Exercise | A | 0.67 | 8,000 | 5,360 | 8,000 | |
| Feb 17 2015 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | President and CEO | Option Exercise | A | 0.67 | 25,900 | 17,353 | 25,900 | |
| Feb 17 2015 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | President and CEO | Grant | A | 0.00 | 48,100 | 0 | 340,725 | 292.6 K to 340.7 K (+16.44 %) |
| Feb 17 2015 | ABIO | ARCA biopharma, In ... | Selby Brian L. | VP, Finance | Option Exercise | A | 0.67 | 12,600 | 8,442 | 12,600 | |
| Feb 17 2015 | ABIO | ARCA biopharma, In ... | Selby Brian L. | VP, Finance | Grant | A | 0.00 | 23,400 | 0 | 34,566 | 11.2 K to 34.6 K (+209.56 %) |
| Feb 17 2015 | ABIO | ARCA biopharma, In ... | Grais Linda S | Director | Option Exercise | A | 0.67 | 8,000 | 5,360 | 8,000 | |
| Feb 17 2015 | ABIO | ARCA biopharma, In ... | MITCHELL DANIEL J | Director | Option Exercise | A | 0.67 | 8,000 | 5,360 | 8,000 | |
| Jan 16 2015 | ABIO | ARCA biopharma, In ... | mccormack riley | 10% Owner | Sell | S | 0.75 | 100,000 | 75,000 | 2,100,000 | 2.2 M to 2.1 M (-4.55 %) |
| Jan 16 2015 | ABIO | ARCA biopharma, In ... | mccormack riley | 10% Owner | Sell | S | 0.75 | 125,000 | 93,750 | 2,200,000 | 2.3 M to 2.2 M (-5.38 %) |
| Jan 16 2015 | ABIO | ARCA biopharma, In ... | mccormack riley | 10% Owner | Sell | S | 0.79 | 125,000 | 98,750 | 2,325,000 | 2.5 M to 2.3 M (-5.10 %) |
| Jan 07 2015 | ABIO | ARCA biopharma, In ... | mccormack riley | 10% Owner | Sell | S | 0.87 | 200,000 | 174,000 | 2,450,000 | 2.7 M to 2.5 M (-7.55 %) |
| Jan 07 2015 | ABIO | ARCA biopharma, In ... | mccormack riley | 10% Owner | Sell | S | 0.92 | 200,000 | 184,000 | 2,650,000 | 2.9 M to 2.7 M (-7.02 %) |
| Jan 07 2015 | ABIO | ARCA biopharma, In ... | mccormack riley | 10% Owner | Sell | S | 0.97 | 150,000 | 145,500 | 2,850,000 | 3 M to 2.9 M (-5.00 %) |
| Sep 19 2014 | ABIO | ARCA biopharma, In ... | Wheeler Patrick M | Chief Financial Off ... | Sell | S | 1.31 | 8,246 | 10,802 | 101,510 | 109.8 K to 101.5 K (-7.51 %) |
| Sep 19 2014 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | President and CEO | Sell | S | 1.30 | 13,853 | 18,009 | 292,625 | 306.5 K to 292.6 K (-4.52 %) |
| Mar 03 2014 | ABIO | ARCA biopharma, In ... | Wheeler Patrick M | Chief Financial Off ... | Option Exercise | A | 1.95 | 20,500 | 39,975 | 20,500 | |
| Mar 03 2014 | ABIO | ARCA biopharma, In ... | Wheeler Patrick M | Chief Financial Off ... | Grant | A | 1.95 | 34,200 | 66,690 | 109,756 | 75.6 K to 109.8 K (+45.26 %) |
| Mar 03 2014 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | President and CEO | Option Exercise | A | 1.95 | 51,500 | 100,425 | 51,500 | |
| Mar 03 2014 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | President and CEO | Grant | A | 1.95 | 56,700 | 110,565 | 306,478 | 249.8 K to 306.5 K (+22.70 %) |
| Mar 03 2014 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | S.V.P., General Cou ... | Option Exercise | A | 1.95 | 10,500 | 20,475 | 10,500 | |
| Mar 03 2014 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | S.V.P., General Cou ... | Grant | A | 1.95 | 34,200 | 66,690 | 126,737 | 92.5 K to 126.7 K (+36.96 %) |
| Feb 13 2014 | ABIO | ARCA biopharma, In ... | Woosley Raymond L. | Director | Option Exercise | A | 1.80 | 8,000 | 14,400 | 8,000 | |
| Feb 13 2014 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Option Exercise | A | 1.80 | 8,000 | 14,400 | 8,000 | |
| Feb 13 2014 | ABIO | ARCA biopharma, In ... | Grais Linda S | Director | Option Exercise | A | 1.80 | 8,000 | 14,400 | 8,000 | |
| Feb 04 2014 | ABIO | ARCA biopharma, In ... | mccormack riley | 10% Owner | Option Exercise | P | 2.13 | 250,000 | 531,250 | 250,000 | |
| Feb 04 2014 | ABIO | ARCA biopharma, In ... | mccormack riley | 10% Owner | Buy | P | 1.70 | 1,000,000 | 1,700,000 | 3,000,000 | 2 M to 3 M (+50.00 %) |
| Sep 19 2013 | ABIO | ARCA biopharma, In ... | ZABRISKIE JOHN L | Director | Option Exercise | A | 1.38 | 7,417 | 10,235 | 7,417 | |
| Sep 19 2013 | ABIO | ARCA biopharma, In ... | ZABRISKIE JOHN L | Director | Option Exercise | A | 1.38 | 16,000 | 22,080 | 16,000 | |
| Sep 19 2013 | ABIO | ARCA biopharma, In ... | Wheeler Patrick M | Chief Financial Off ... | Option Exercise | A | 1.38 | 81,856 | 112,961 | 81,856 | |
| Sep 19 2013 | ABIO | ARCA biopharma, In ... | Wheeler Patrick M | Chief Financial Off ... | Grant | A | 1.38 | 75,000 | 103,500 | 75,556 | 556 to 75.6 K (+13,489.21 %) |
| Sep 19 2013 | ABIO | ARCA biopharma, In ... | Woosley Raymond L. | Director | Option Exercise | A | 1.38 | 3,463 | 4,779 | 3,463 | |
| Sep 19 2013 | ABIO | ARCA biopharma, In ... | Woosley Raymond L. | Director | Option Exercise | A | 1.38 | 14,750 | 20,355 | 14,750 | |
| Sep 19 2013 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | Pres & CEO | Option Exercise | A | 1.38 | 282,825 | 390,299 | 282,825 | |
| Sep 19 2013 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | Pres & CEO | Grant | A | 1.38 | 125,000 | 172,500 | 249,778 | 124.8 K to 249.8 K (+100.18 %) |
| Sep 19 2013 | ABIO | ARCA biopharma, In ... | Grais Linda S | Director | Option Exercise | A | 1.38 | 7,417 | 10,235 | 7,417 | |
| Sep 19 2013 | ABIO | ARCA biopharma, In ... | Grais Linda S | Director | Option Exercise | A | 1.38 | 16,000 | 22,080 | 16,000 | |
| Sep 19 2013 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Option Exercise | A | 1.38 | 2,608 | 3,599 | 2,608 | |
| Sep 19 2013 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Option Exercise | A | 1.38 | 14,750 | 20,355 | 14,750 | |
| Sep 19 2013 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | S.V.P., General Cou ... | Option Exercise | A | 1.38 | 42,642 | 58,846 | 42,642 | |
| Sep 19 2013 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | S.V.P., General Cou ... | Grant | A | 1.38 | 75,000 | 103,500 | 92,537 | 17.5 K to 92.5 K (+427.67 %) |
| Jul 30 2013 | ABIO | ARCA biopharma, In ... | Grais Linda S | Director | Option Exercise | A | 1.40 | 583 | 816 | 583 | |
| Jul 30 2013 | ABIO | ARCA biopharma, In ... | ZABRISKIE JOHN L | Director | Option Exercise | A | 1.40 | 583 | 816 | 583 | |
| Jun 14 2013 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | President and CEO | Option Exercise | C | 0.00 | 781 | 0 | 0 | |
| Jun 14 2013 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | President and CEO | Buy | C | 0.00 | 78,100 | 0 | 124,778 | 46.7 K to 124.8 K (+167.32 %) |
| Jun 06 2013 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | President and CEO | Option Exercise | A | 1.60 | 39,050 | 62,480 | 39,050 | |
| Jun 06 2013 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | President and CEO | Option Exercise | A | 0.00 | 781 | 0 | 781 | |
| Jan 28 2013 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | President and CEO | Option Exercise | P | 0.38 | 748,503 | 284,506 | 748,503 | |
| Jan 28 2013 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | President and CEO | Buy | P | 0.47 | 1,069,290 | 500,000 | 1,069,290 | 0 to 1.1 M |
| Dec 20 2012 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | President and CEO | Option Exercise | A | 0.39 | 387,837 | 151,140 | 387,837 | |
| Dec 20 2012 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | President and CEO | Grant | A | 0.48 | 517,116 | 250,026 | 834,495 | 317.4 K to 834.5 K (+162.93 %) |
| Oct 24 2012 | ABIO | ARCA biopharma, In ... | FORMELA JEAN FRANCOIS | Director | Option Exercise | A | 0.30 | 238,034 | 71,434 | 313,483 | |
| Oct 24 2012 | ABIO | ARCA biopharma, In ... | FORMELA JEAN FRANCOIS | Director | Grant | A | 0.39 | 317,379 | 125,016 | 1,579,542 | 1.3 M to 1.6 M (+25.15 %) |
| Oct 24 2012 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | President and CEO | Option Exercise | A | 0.30 | 238,034 | 71,434 | 238,024 | |
| Oct 24 2012 | ABIO | ARCA biopharma, In ... | BRISTOW MICHAEL R | President and CEO | Grant | A | 0.39 | 317,379 | 125,016 | 317,379 | 0 to 317.4 K |
| Oct 24 2012 | ABIO | ARCA biopharma, In ... | ZABRISKIE JOHN L | Director | Option Exercise | A | 0.30 | 95,213 | 28,573 | 95,213 | |
| Oct 24 2012 | ABIO | ARCA biopharma, In ... | ZABRISKIE JOHN L | Director | Grant | A | 0.39 | 126,951 | 50,006 | 156,131 | 29.2 K to 156.1 K (+435.06 %) |
| Oct 24 2012 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | SVP and General Cou ... | Option Exercise | A | 0.30 | 47,606 | 14,287 | 47,606 | |
| Oct 24 2012 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | SVP and General Cou ... | Grant | A | 0.39 | 63,475 | 25,003 | 105,233 | 41.8 K to 105.2 K (+152.01 %) |
| Feb 14 2012 | ABIO | ARCA biopharma, In ... | Grais Linda S | Director | Option Exercise | A | 1.00 | 3,500 | 3,500 | 3,500 | |
| Feb 14 2012 | ABIO | ARCA biopharma, In ... | Grais Linda S | Director | Option Exercise | A | 1.00 | 3,500 | 3,500 | 3,500 | |
| Feb 14 2012 | ABIO | ARCA biopharma, In ... | BREWER RICHARD B | Director | Option Exercise | A | 1.00 | 3,500 | 3,500 | 3,500 | |
| Feb 14 2012 | ABIO | ARCA biopharma, In ... | BREWER RICHARD B | Director | Option Exercise | A | 1.00 | 3,500 | 3,500 | 3,500 | |
| Feb 14 2012 | ABIO | ARCA biopharma, In ... | SOBEL BURTON E | Director | Option Exercise | A | 1.00 | 3,500 | 3,500 | 3,500 | |
| Feb 14 2012 | ABIO | ARCA biopharma, In ... | SOBEL BURTON E | Director | Option Exercise | A | 1.00 | 3,500 | 3,500 | 3,500 | |
| Feb 14 2012 | ABIO | ARCA biopharma, In ... | FORMELA JEAN FRANCOIS | Director | Option Exercise | A | 1.00 | 3,500 | 3,500 | 3,500 | |
| Feb 14 2012 | ABIO | ARCA biopharma, In ... | FORMELA JEAN FRANCOIS | Director | Option Exercise | A | 1.00 | 3,500 | 3,500 | 3,500 | |
| Feb 14 2012 | ABIO | ARCA biopharma, In ... | ZABRISKIE JOHN L | Director | Option Exercise | A | 1.00 | 3,500 | 3,500 | 3,500 |